To compare different iron therapy for anemic pregnant wome
Not Applicable
- Conditions
- Health Condition 1: O093- Supervision of pregnancy with insufficient antenatal care
- Registration Number
- CTRI/2020/04/024548
- Lead Sponsor
- Dr Shreedevi Kori
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a.All the antenatal women with 16 to 34 weeks period of gestation.
b.All the antenatal women who are diagnosed with iron deficiency anemia
with HB 7-10.9gm%
c.All the antenatal women with singleton pregnancy.
Exclusion Criteria
1.Any Blood transfusion or have undergone iron theray within 3 months.
2.Anaemia not caused by iron deficiency.
3.Evidence of any significant abnormalities on anomaly ultrasound.
4.Known hypersensitivity to FCM or other IV iron preparations.
5.History of fever or chronic illness like malaria, dengue, diarrhea , dysentery and piles.
6.Not consenting
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO STUDY THE EFFICACY OF Oral iron therapy Intravenous Ferric Carboxymaltose VS Iron Sucrose In The Treatment Of Iron Deficiency Aaemia During PregnancyTimepoint: after 3 weeks to compare serum ferritin levels and complete blood count
- Secondary Outcome Measures
Name Time Method To Study the Efficacy Of Intravenous Ferric Carboxymaltose VS Iron Sucrose VS Oral Iron therapy in the treatment of iron deficiency anemia during pregnancyTimepoint: after 6 weeks to compare serum ferritin levels and complete blood count